APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Advanced Strain-Engineered Microbial Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Advanced Strain-Engineered Microbial Platform Market Analysis and Forecast 2026-2032

Report ID 174052950222 January 2026193 pages

Choose your research edition.

Industry ResearchAdvanced Strain-Engineered Microbial Platform Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Advanced Strain-Engineered Microbial Platform Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Advanced Strain-Engineered Microbial Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Advanced Strain-Engineered Microbial Platform Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Advanced Strain-Engineered Microbial Platform Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Advanced Strain-Engineered Microbial Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Advanced Strain-Engineered Microbial Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Advanced Strain-Engineered Microbial Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Advanced Strain-Engineered Microbial Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Advanced Strain-Engineered Microbial Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Advanced Strain-Engineered Microbial Platform include Ginkgo Bioworks, Amyris, Zymergen, Codexis, Novozymes, DSM-Firmenich, Evonik, Genomatica and LanzaTech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Advanced Strain-Engineered Microbial Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Advanced Strain-Engineered Microbial Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Advanced Strain-Engineered Microbial Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Advanced Strain-Engineered Microbial Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Advanced Strain-Engineered Microbial Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Advanced Strain-Engineered Microbial Platform revenue, projected growth trends, production technology, application and end-user industry.

Advanced Strain-Engineered Microbial Platform Segment by Company

Ginkgo Bioworks

Amyris

Zymergen

Codexis

Novozymes

DSM-Firmenich

Evonik

Genomatica

LanzaTech

Conagen

Arzeda

BitBio

Advanced Strain-Engineered Microbial Platform Segment by Type

Escherichia Coli

Yeast (Saccharomyces)

Filamentous Fungi

Bacillus Species

Non-Model / Custom Hosts

Advanced Strain-Engineered Microbial Platform Segment by Application

Pharmaceuticals

Industrial Chemicals

Food & Beverage

Agriculture & AgBio

Materials & Polymers

Others

Advanced Strain-Engineered Microbial Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Strain-Engineered Microbial Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Advanced Strain-Engineered Microbial Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Strain-Engineered Microbial Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Advanced Strain-Engineered Microbial Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Advanced Strain-Engineered Microbial Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Advanced Strain-Engineered Microbial Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Advanced Strain-Engineered Microbial Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Escherichia Coli Major Player Table 3. Yeast (Saccharomyces) Major Player Table 4. Filamentous Fungi Major Player Table 5. Bacillus Species Major Player Table 6. Non-Model / Custom Hosts Major Player Table 7. Global Advanced Strain-Engineered Microbial Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Pharmaceuticals Major Player Table 9. Industrial Chemicals Major Player Table 10. Food & Beverage Major Player Table 11. Agriculture & AgBio Major Player Table 12. Materials & Polymers Major Player Table 13. Others Major Player Table 14. Advanced Strain-Engineered Microbial Platform Industry Trends Table 15. Advanced Strain-Engineered Microbial Platform Industry Drivers Table 16. Advanced Strain-Engineered Microbial Platform Industry Opportunities and Challenges Table 17. Advanced Strain-Engineered Microbial Platform Industry Restraints Table 18. Global Advanced Strain-Engineered Microbial Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 19. Global Advanced Strain-Engineered Microbial Platform Market Size by Region (2021-2026) & (US$ Million) Table 20. Global Advanced Strain-Engineered Microbial Platform Market Share by Region (2021-2026) Table 21. Global Advanced Strain-Engineered Microbial Platform Market Size by Region (2027-2032) & (US$ Million) Table 22. Global Advanced Strain-Engineered Microbial Platform Market Share by Region (2027-2032) Table 23. Global Advanced Strain-Engineered Microbial Platform Revenue by Players (US$ Million) & (2021-2026) Table 24. Global Advanced Strain-Engineered Microbial Platform Revenue Market Share by Players (2021-2026) Table 25. Global Advanced Strain-Engineered Microbial Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 26. Global Advanced Strain-Engineered Microbial Platform Key Players Headquarters & Area Served Table 27. Global Advanced Strain-Engineered Microbial Platform Players, Product Type & Application Table 28. Global Advanced Strain-Engineered Microbial Platform Players Establishment Date Table 29. Global Players Market Concentration Ratio (CR5 and HHI) Table 30. Global Advanced Strain-Engineered Microbial Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 31. Global Advanced Strain-Engineered Microbial Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2026) & (US$ Million) Table 33. Global Advanced Strain-Engineered Microbial Platform Revenue by Type (2027-2032) & (US$ Million) Table 34. Global Advanced Strain-Engineered Microbial Platform Revenue Market Share by Type (2021-2026) Table 35. Global Advanced Strain-Engineered Microbial Platform Revenue Market Share by Type (2027-2032) Table 36. Global Advanced Strain-Engineered Microbial Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2026) & (US$ Million) Table 38. Global Advanced Strain-Engineered Microbial Platform Revenue by Application (2027-2032) & (US$ Million) Table 39. Global Advanced Strain-Engineered Microbial Platform Revenue Market Share by Application (2021-2026) Table 40. Global Advanced Strain-Engineered Microbial Platform Revenue Market Share by Application (2027-2032) Table 41. Ginkgo Bioworks Company Information Table 42. Ginkgo Bioworks Business Overview Table 43. Ginkgo Bioworks Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Ginkgo Bioworks Advanced Strain-Engineered Microbial Platform Product Portfolio Table 45. Ginkgo Bioworks Recent Development Table 46. Amyris Company Information Table 47. Amyris Business Overview Table 48. Amyris Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Amyris Advanced Strain-Engineered Microbial Platform Product Portfolio Table 50. Amyris Recent Development Table 51. Zymergen Company Information Table 52. Zymergen Business Overview Table 53. Zymergen Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Zymergen Advanced Strain-Engineered Microbial Platform Product Portfolio Table 55. Zymergen Recent Development Table 56. Codexis Company Information Table 57. Codexis Business Overview Table 58. Codexis Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Codexis Advanced Strain-Engineered Microbial Platform Product Portfolio Table 60. Codexis Recent Development Table 61. Novozymes Company Information Table 62. Novozymes Business Overview Table 63. Novozymes Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Novozymes Advanced Strain-Engineered Microbial Platform Product Portfolio Table 65. Novozymes Recent Development Table 66. DSM-Firmenich Company Information Table 67. DSM-Firmenich Business Overview Table 68. DSM-Firmenich Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. DSM-Firmenich Advanced Strain-Engineered Microbial Platform Product Portfolio Table 70. DSM-Firmenich Recent Development Table 71. Evonik Company Information Table 72. Evonik Business Overview Table 73. Evonik Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Evonik Advanced Strain-Engineered Microbial Platform Product Portfolio Table 75. Evonik Recent Development Table 76. Genomatica Company Information Table 77. Genomatica Business Overview Table 78. Genomatica Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Genomatica Advanced Strain-Engineered Microbial Platform Product Portfolio Table 80. Genomatica Recent Development Table 81. LanzaTech Company Information Table 82. LanzaTech Business Overview Table 83. LanzaTech Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. LanzaTech Advanced Strain-Engineered Microbial Platform Product Portfolio Table 85. LanzaTech Recent Development Table 86. Conagen Company Information Table 87. Conagen Business Overview Table 88. Conagen Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Conagen Advanced Strain-Engineered Microbial Platform Product Portfolio Table 90. Conagen Recent Development Table 91. Arzeda Company Information Table 92. Arzeda Business Overview Table 93. Arzeda Advanced Strain-Engineered Microbial Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Arzeda Advanced Strain-Engineered Microbial Platform Product Portfolio Table 95. Arzeda Recent Development Table 96. BitBio Company Information Table 97. BitBio Business Overview Table 98. BitBio Advanced Strain-Engineered Microbial Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. BitBio Advanced Strain-Engineered Microbial Platform Product Portfolio Table 100. BitBio Recent Development Table 101. North America Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Advanced Strain-Engineered Microbial Platform Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Advanced Strain-Engineered Microbial Platform Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Advanced Strain-Engineered Microbial Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Advanced Strain-Engineered Microbial Platform Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Advanced Strain-Engineered Microbial Platform Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Advanced Strain-Engineered Microbial Platform Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Advanced Strain-Engineered Microbial Platform Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Advanced Strain-Engineered Microbial Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Advanced Strain-Engineered Microbial Platform Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Advanced Strain-Engineered Microbial Platform Revenue by Country (US$ Million) & (2027-2032) Table 115. China Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2026) & (US$ Million) Table 116. China Advanced Strain-Engineered Microbial Platform Revenue by Type (2027-2032) & (US$ Million) Table 117. China Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2026) & (US$ Million) Table 118. China Advanced Strain-Engineered Microbial Platform Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Advanced Strain-Engineered Microbial Platform Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Advanced Strain-Engineered Microbial Platform Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Advanced Strain-Engineered Microbial Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Advanced Strain-Engineered Microbial Platform Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Advanced Strain-Engineered Microbial Platform Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Advanced Strain-Engineered Microbial Platform Image Figure 2. Global Advanced Strain-Engineered Microbial Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Advanced Strain-Engineered Microbial Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Escherichia Coli Image Figure 5. Yeast (Saccharomyces) Image Figure 6. Filamentous Fungi Image Figure 7. Bacillus Species Image Figure 8. Non-Model / Custom Hosts Image Figure 9. Global Advanced Strain-Engineered Microbial Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Advanced Strain-Engineered Microbial Platform Market Size Share 2021 VS 2025 VS 2032 Figure 11. Pharmaceuticals Image Figure 12. Industrial Chemicals Image Figure 13. Food & Beverage Image Figure 14. Agriculture & AgBio Image Figure 15. Materials & Polymers Image Figure 16. Others Image Figure 17. Global Advanced Strain-Engineered Microbial Platform Market Size (US$ Million) & (2021-2032) Figure 18. Global Advanced Strain-Engineered Microbial Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Advanced Strain-Engineered Microbial Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 20. Global Advanced Strain-Engineered Microbial Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Advanced Strain-Engineered Microbial Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Advanced Strain-Engineered Microbial Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Advanced Strain-Engineered Microbial Platform Revenue Market Share by Type (2021-2032) Figure 25. Global Advanced Strain-Engineered Microbial Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Advanced Strain-Engineered Microbial Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 27. Global Advanced Strain-Engineered Microbial Platform Revenue Market Share by Application (2021-2032) Figure 28. North America Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. North America Advanced Strain-Engineered Microbial Platform Revenue Share by Type (2021-2032) Figure 30. North America Advanced Strain-Engineered Microbial Platform Revenue Share by Application (2021-2032) Figure 31. North America Advanced Strain-Engineered Microbial Platform Revenue Share by Country (2021-2032) Figure 32. United States Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Canada Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Mexico Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Europe Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 36. Europe Advanced Strain-Engineered Microbial Platform Revenue Share by Type (2021-2032) Figure 37. Europe Advanced Strain-Engineered Microbial Platform Revenue Share by Application (2021-2032) Figure 38. Europe Advanced Strain-Engineered Microbial Platform Revenue Share by Country (2021-2032) Figure 39. Germany Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. France Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. U.K. Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Italy Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Spain Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Russia Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Netherlands Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. Nordic Countries Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 47. China Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. China Advanced Strain-Engineered Microbial Platform Revenue Share by Type (2021-2032) Figure 49. China Advanced Strain-Engineered Microbial Platform Revenue Share by Application (2021-2032) Figure 50. Asia Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 51. Asia Advanced Strain-Engineered Microbial Platform Revenue Share by Type (2021-2032) Figure 52. Asia Advanced Strain-Engineered Microbial Platform Revenue Share by Application (2021-2032) Figure 53. Asia Advanced Strain-Engineered Microbial Platform Revenue Share by Region (2021-2032) Figure 54. Japan Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. South Korea Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. India Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Australia Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Taiwan Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Southeast Asia Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. SAMEA Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 61. SAMEA Advanced Strain-Engineered Microbial Platform Revenue Share by Type (2021-2032) Figure 62. SAMEA Advanced Strain-Engineered Microbial Platform Revenue Share by Application (2021-2032) Figure 63. SAMEA Advanced Strain-Engineered Microbial Platform Revenue Share by Country (2021-2032) Figure 64. Brazil Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Argentina Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Chile Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Colombia Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Peru Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Saudi Arabia Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Israel Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. UAE Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Turkey Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Iran Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Egypt Advanced Strain-Engineered Microbial Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Escherichia Coli
  • Yeast (Saccharomyces)
  • Filamentous Fungi
  • Bacillus Species
  • Non-Model / Custom Hosts
Applications
  • Pharmaceuticals
  • Industrial Chemicals
  • Food & Beverage
  • Agriculture & AgBio
  • Materials & Polymers
  • Others
Companies covered
  • Ginkgo Bioworks
  • Amyris
  • Zymergen
  • Codexis
  • Novozymes
  • DSM-Firmenich
  • Evonik
  • Genomatica
  • LanzaTech
  • Conagen
  • Arzeda
  • BitBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Advanced Strain-Engineered Microbial Platform Market by Type
  3. 1.2.1 Global Advanced Strain-Engineered Microbial Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Escherichia Coli
  5. 1.2.3 Yeast (Saccharomyces)
  6. 1.2.4 Filamentous Fungi
  7. 1.2.5 Bacillus Species
  8. 1.2.6 Non-Model / Custom Hosts
  9. 1.3 Advanced Strain-Engineered Microbial Platform Market by Application
  10. 1.3.1 Global Advanced Strain-Engineered Microbial Platform Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Pharmaceuticals
  12. 1.3.3 Industrial Chemicals
  13. 1.3.4 Food & Beverage
  14. 1.3.5 Agriculture & AgBio
  15. 1.3.6 Materials & Polymers
  16. 1.3.7 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Advanced Strain-Engineered Microbial Platform Market Dynamics
  1. 2.1 Advanced Strain-Engineered Microbial Platform Industry Trends
  2. 2.2 Advanced Strain-Engineered Microbial Platform Industry Drivers
  3. 2.3 Advanced Strain-Engineered Microbial Platform Industry Opportunities and Challenges
  4. 2.4 Advanced Strain-Engineered Microbial Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Advanced Strain-Engineered Microbial Platform Market Perspective (2021-2032)
  2. 3.2 Global Advanced Strain-Engineered Microbial Platform Growth Trends by Region
  3. 3.2.1 Global Advanced Strain-Engineered Microbial Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Advanced Strain-Engineered Microbial Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global Advanced Strain-Engineered Microbial Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Advanced Strain-Engineered Microbial Platform Revenue by Players
  2. 4.1.1 Global Advanced Strain-Engineered Microbial Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global Advanced Strain-Engineered Microbial Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Advanced Strain-Engineered Microbial Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Advanced Strain-Engineered Microbial Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Advanced Strain-Engineered Microbial Platform Key Players Headquarters & Area Served
  7. 4.4 Global Advanced Strain-Engineered Microbial Platform Players, Product Type & Application
  8. 4.5 Global Advanced Strain-Engineered Microbial Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Advanced Strain-Engineered Microbial Platform Market CR5 and HHI
  11. 4.6.3 2025 Advanced Strain-Engineered Microbial Platform Tier 1, Tier 2, and Tier 3
5 Advanced Strain-Engineered Microbial Platform Market Size by Type
  1. 5.1 Global Advanced Strain-Engineered Microbial Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2032)
  3. 5.3 Global Advanced Strain-Engineered Microbial Platform Revenue Market Share by Type (2021-2032)
6 Advanced Strain-Engineered Microbial Platform Market Size by Application
  1. 6.1 Global Advanced Strain-Engineered Microbial Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2032)
  3. 6.3 Global Advanced Strain-Engineered Microbial Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Ginkgo Bioworks
  2. 7.1.1 Ginkgo Bioworks Company Information
  3. 7.1.2 Ginkgo Bioworks Business Overview
  4. 7.1.3 Ginkgo Bioworks Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Ginkgo Bioworks Advanced Strain-Engineered Microbial Platform Product Portfolio
  6. 7.1.5 Ginkgo Bioworks Recent Developments
  7. 7.2 Amyris
  8. 7.2.1 Amyris Company Information
  9. 7.2.2 Amyris Business Overview
  10. 7.2.3 Amyris Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Amyris Advanced Strain-Engineered Microbial Platform Product Portfolio
  12. 7.2.5 Amyris Recent Developments
  13. 7.3 Zymergen
  14. 7.3.1 Zymergen Company Information
  15. 7.3.2 Zymergen Business Overview
  16. 7.3.3 Zymergen Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Zymergen Advanced Strain-Engineered Microbial Platform Product Portfolio
  18. 7.3.5 Zymergen Recent Developments
  19. 7.4 Codexis
  20. 7.4.1 Codexis Company Information
  21. 7.4.2 Codexis Business Overview
  22. 7.4.3 Codexis Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Codexis Advanced Strain-Engineered Microbial Platform Product Portfolio
  24. 7.4.5 Codexis Recent Developments
  25. 7.5 Novozymes
  26. 7.5.1 Novozymes Company Information
  27. 7.5.2 Novozymes Business Overview
  28. 7.5.3 Novozymes Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Novozymes Advanced Strain-Engineered Microbial Platform Product Portfolio
  30. 7.5.5 Novozymes Recent Developments
  31. 7.6 DSM-Firmenich
  32. 7.6.1 DSM-Firmenich Company Information
  33. 7.6.2 DSM-Firmenich Business Overview
  34. 7.6.3 DSM-Firmenich Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 DSM-Firmenich Advanced Strain-Engineered Microbial Platform Product Portfolio
  36. 7.6.5 DSM-Firmenich Recent Developments
  37. 7.7 Evonik
  38. 7.7.1 Evonik Company Information
  39. 7.7.2 Evonik Business Overview
  40. 7.7.3 Evonik Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Evonik Advanced Strain-Engineered Microbial Platform Product Portfolio
  42. 7.7.5 Evonik Recent Developments
  43. 7.8 Genomatica
  44. 7.8.1 Genomatica Company Information
  45. 7.8.2 Genomatica Business Overview
  46. 7.8.3 Genomatica Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Genomatica Advanced Strain-Engineered Microbial Platform Product Portfolio
  48. 7.8.5 Genomatica Recent Developments
  49. 7.9 LanzaTech
  50. 7.9.1 LanzaTech Company Information
  51. 7.9.2 LanzaTech Business Overview
  52. 7.9.3 LanzaTech Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 LanzaTech Advanced Strain-Engineered Microbial Platform Product Portfolio
  54. 7.9.5 LanzaTech Recent Developments
  55. 7.10 Conagen
  56. 7.10.1 Conagen Company Information
  57. 7.10.2 Conagen Business Overview
  58. 7.10.3 Conagen Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Conagen Advanced Strain-Engineered Microbial Platform Product Portfolio
  60. 7.10.5 Conagen Recent Developments
  61. 7.11 Arzeda
  62. 7.11.1 Arzeda Company Information
  63. 7.11.2 Arzeda Business Overview
  64. 7.11.3 Arzeda Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Arzeda Advanced Strain-Engineered Microbial Platform Product Portfolio
  66. 7.11.5 Arzeda Recent Developments
  67. 7.12 BitBio
  68. 7.12.1 BitBio Company Information
  69. 7.12.2 BitBio Business Overview
  70. 7.12.3 BitBio Advanced Strain-Engineered Microbial Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 BitBio Advanced Strain-Engineered Microbial Platform Product Portfolio
  72. 7.12.5 BitBio Recent Developments
8 North America
  1. 8.1 North America Advanced Strain-Engineered Microbial Platform Revenue (2021-2032)
  2. 8.2 North America Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America Advanced Strain-Engineered Microbial Platform Revenue by Type (2027-2032)
  5. 8.3 North America Advanced Strain-Engineered Microbial Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America Advanced Strain-Engineered Microbial Platform Revenue by Application (2027-2032)
  9. 8.5 North America Advanced Strain-Engineered Microbial Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America Advanced Strain-Engineered Microbial Platform Revenue by Country
  11. 8.6.1 North America Advanced Strain-Engineered Microbial Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Advanced Strain-Engineered Microbial Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America Advanced Strain-Engineered Microbial Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Advanced Strain-Engineered Microbial Platform Revenue (2021-2032)
  2. 9.2 Europe Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe Advanced Strain-Engineered Microbial Platform Revenue by Type (2027-2032)
  5. 9.3 Europe Advanced Strain-Engineered Microbial Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe Advanced Strain-Engineered Microbial Platform Revenue by Application (2027-2032)
  9. 9.5 Europe Advanced Strain-Engineered Microbial Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe Advanced Strain-Engineered Microbial Platform Revenue by Country
  11. 9.6.1 Europe Advanced Strain-Engineered Microbial Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Advanced Strain-Engineered Microbial Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe Advanced Strain-Engineered Microbial Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Advanced Strain-Engineered Microbial Platform Revenue (2021-2032)
  2. 10.2 China Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2032)
  3. 10.2.1 China Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2026)
  4. 10.2.2 China Advanced Strain-Engineered Microbial Platform Revenue by Type (2027-2032)
  5. 10.3 China Advanced Strain-Engineered Microbial Platform Revenue Share by Type (2021-2032)
  6. 10.4 China Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2032)
  7. 10.4.1 China Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2026)
  8. 10.4.2 China Advanced Strain-Engineered Microbial Platform Revenue by Application (2027-2032)
  9. 10.5 China Advanced Strain-Engineered Microbial Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Advanced Strain-Engineered Microbial Platform Revenue (2021-2032)
  2. 11.2 Asia Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia Advanced Strain-Engineered Microbial Platform Revenue by Type (2027-2032)
  5. 11.3 Asia Advanced Strain-Engineered Microbial Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia Advanced Strain-Engineered Microbial Platform Revenue by Application (2027-2032)
  9. 11.5 Asia Advanced Strain-Engineered Microbial Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia Advanced Strain-Engineered Microbial Platform Revenue by Country
  11. 11.6.1 Asia Advanced Strain-Engineered Microbial Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Advanced Strain-Engineered Microbial Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia Advanced Strain-Engineered Microbial Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Advanced Strain-Engineered Microbial Platform Revenue (2021-2032)
  2. 12.2 SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA Advanced Strain-Engineered Microbial Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA Advanced Strain-Engineered Microbial Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Country
  11. 12.6.1 SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Advanced Strain-Engineered Microbial Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst